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Abstract 
Review on C2orf3, with data on DNA, on the protein 
encoded, and where the gene isimplicated. 
Keywords 
post-splicing, turnover of mRNA, lariat intron, 
dyslexia 
Identity 
Other names 
GCFC2 GC-rich sequence DNA-binding factor 2 
HGNC (Hugo) 
GCFC2 
Location 
2p12 
Structural Relation among C2orf3, GCF and GCF2. GCF is an artificial cDNA composed of GCF2 and C2orf3 
Note 
C2orf3 gene was discovered as a C-terminal side of 
GCF cDNA, which is an artificial chimeric one 
(Kageyama and Pastan, 1989;Takimoto et al., 1999) 
. As C2orf3 protein is a factor that plays a role in 
splicing of mRNA (Yoshimoto et al., 2014) and the 
protein encoded by a N-terminal side of GCF cDNA, 
which is a bona fide transcriptional repressor termed 
GCF2, binds to the GC rich element of DNA (Reed 
et al., 1998), the nomenclature of this gene as 
GCFC2 is inappropriate. 
Major data bases, such as provided by University of 
California Santa Cruz (UCSC), National Center for 
Biotechnology Information (NCBI) and Hugo Gene 
Nomenclature Committee (HGNC), use GCFC2 to 
describe this gene. For example, UCSC genome 
browser describes this gene as GCFC2, which is 
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present next to MRP19 gene in the chromosomal 
2p12 region (Anthoni et al., 2007). 
As C2orf3 does not bind to the GC-rich sequence 
(Takimoto et al., 1999), the use of the term GCFC2 
for this gene is misleading and we think it should not 
be used. 
DNA/RNA 
Description 
Genomic DNA  
Genomic size of DNA is about 50 kbp and consists 
of 17 exons. >  
 
 cDNA   
GCF was originally discovered as a gene that 
encodes a transcriptional repressor that binds to a 
GC-rich sequence of the regulatory regions of 
human EGF-R gene  (Kageyama and Pastan, 1989). 
However, a following study showed that GCF cDNA 
is an artificial fusion molecule between two different 
cDNAs; The 5' side of the cDNA encodes a highly 
basic region with the sequence-specific binding 
activity to the GC-rich region and the 3' side encodes 
most of C2orf3 protein (Takimoto  et al., 1999). 
Reed et al. cloned a full length of the former cDNA 
that has transcriptional repressor activity with the 
sequence-specific DNA binding ability, and named 
this cDNA as GCF2. Following studies had 
confirmed the transcriptional repressive activity of 
GCF2 ( Shibutani M et al., 1998: Khachigian LM et 
al., 1999). The full length of C2orf3 cDNA was 
cloned and its sequence was determined. The cDNA 
is composed of 2661 nucleotides and encodes a 
protein of 781 amino acids. The encoded protein 
does not contain the highly basic region of the 
published GCF and has no sequence-specific DNA 
binding activity to the GC-rich sequence (Takimoto  
et al., 1999)   
 
cDNA sequence: (GenBank: AB026911)  
GGGCGGGCACTGAAGCTGCGGCTTGCGGTT
CAGCGGGTTCTAGGGCGCCGGGCGCTCGGG
CCTCGGCCATGGCTCACAGGCCGAAAAGGA
CTTTTCGGCA 
GCGCGCGGCTGATTCCAGCGACAGCGATGG
CGCCGAGGAGTCGCCTGCTGAGCCTGGGGC
GCCGAGGGAACTTCCGGTCCCGGGTTCTGC
GGAGGAAGAG 
CCGCCCTCTGGAGGAGGCCGCGCGCAGGTG
GCGGGACTGCCCCACCGGGTTCGGGGCCCT
CGTGGCCGGGGCCGGGTCTGGGCGAGCTCC
CGGCGTGCCA 
CCAAAGCGGCTCCCCGCGCGGACGAAGGCT
CAGAATCCAGAACCCTTGATGTGTCCACAG
ATGAAGAGGATAAAATACATCACTCCTCAG
AAAGTAAGGA 
TGATCAGGGTTTGTCTTCTGACAGTTCTAGC
TCTCTTGGAGAAAAAGAACTTTCATCAACA
GTTAAGATCCCAGATGCAGCTTTTATTCAG
GCAGCCCGC 
AGAAAACGTGAATTGGCCAGGGCCCAAGAT
GACTATATTTCTTTGGATGTACAACATACCT
CCTCCATCTCTGGTATGAAGAGAGAGAGCG
AAGATGACC 
CTGAGAGTGAGCCTGATGACCATGAAAAGA
GAATACCATTTACTCTAAGACCTCAAACAC
TTAGACAAAGGATGGCTGAGGAATCAATAA
GCAGAAATGA 
AGAAACAAGTGAAGAAAGTCAGGAAGATG
AAAAGCAAGATACTTGGGAACAACAGCAA
ATGAGGAAAGCAGTTAAAATCATAGAGGA
AAGAGACATAGAT 
CTTTCCTGTGGCAGTGGATCTTCAAAAGTG
AAGAAATTTGATACTTCCATTTCATTTCCGC
CAGTAAATTTAGAAATTATAAAGAAGCAAT
TAAATACTA 
GATTAACATTACTACAGGAAACTCACCGCT
CACACCTGAGGGAGTATGAAAAATACGTAC
AAGATGTCAAAAGCTCAAAGAGTACCATCC
AGAACCTAGA 
GAGTTCATCAAATCAAGCTCTAAATTGTAA
ATTCTATAAAAGCATGAAAATTTATGTGGA
AAATTTAATTGACTGCCTTAATGAAAAGAT
TATCAACATC 
CAAGAAATAGAATCATCCATGCATGCACTC
CTTTTAAAACAAGCTATGACCTTTATGAAA
CGCAGGCAAGATGAATTAAAACATGAATCA
ACGTATTTAC 
AACAGTTATCACGCAAAGATGAGACATCCA
CAAGTGGAAACTTCTCAGTAGATGAAAAAA
CTCAGTGGATTTTAGAAGAGATTGAATCTC
GAAGGACAAA 
AAGAAGACAAGCAAGGGTGCTTTCTGGGAA
TTGTAACCATCAGGAAGGAACATCTAGTGA
TGATGAACTGCCTTCAGCAGAGATGATTGA
CTTCCAAAAA 
AGCCAAGGTGACATTTTACAGAAACAGAAG
AAAGTTTTTGAAGAAGTGCAAGATGATTTT
TGTAACATCCAGAATATTTTGTTGAAATTTC
AGCAATGGC 
GAGAAAAGTTTCCTGACTCCTATTATGAAG
CTTTCATTAGTTTATGCATACCAAAGCTTTT
AAATCCCCTAATACGAGTTCAGTTGATTGA
TTGGAATCC 
TCTTAAGTTGGAATCCACAGGTTTAAAAGA
GATGCCATGGTTCAAATCTGTAGAAGAATT
TATGGATAGCAGTGTAGAAGATTCAAAGAA
GGAAAGTAGT 
TCAGATAAAAAAGTCTTGTCTGCAATCATC
AACAAAACAATTATTCCCCGACTTACAGAC
TTTGTAGAATTCCTTTGGGATCCTTTGTCAA
CCTCACAGA 
CAACAAGTTTAATAACACATTGCAGAGTGA
TTCTTGAAGAACATTCCACTTGTGAAAATG
AAGTTAGTAAAAGCAGACAGGATTTACTTA
AATCCATTGT 
TTCAAGAATGAAAAAGGCAGTAGAAGATG
ATGTTTTTATTCCTCTGTATCCAAAGAGTGC
TGTAGAAAACAAAACATCACCTCATTCAAA
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GTTCCAAGAA 
AGACAGTTCTGGTCAGGCCTAAAGCTCTTC
CGCAATATTCTTCTTTGGAATGGACTCCTTA
CAGATGACACCTTGCAAGAACTAGGACTAG
GGAAGCTGC 
TAAATCGTTACCTTATTATAGCACTTCTCAA
TGCCACACCTGGGCCAGATGTGGTTAAAAA
GTGCAACCAGGTAGCAGCATGTCTACCAGA
AAAATGGTT 
TGAAAATTCTGCCATGAGGACATCTATTCC
ACAGCTAGAAAACTTCATTCAGTTTTTATTG
CAGTCTGCACATAAATTATCTAGAAGTGAA
TTCAGGGAT 
GAAGTCGAAGAAATAATTCTTATTTTGGTG
AAAATAAAAGCTTTGAATCAAGCAGAATCC
TTCATAGGAGAGCATCACCTAGACCATCTT
AAATCACTAA 
TTAAAGAAGATTGAATAAACTTTATTGGAA
AATGCTAAAATTTTAATATAGTTACACTCA
GTTCCTTTGTTTGAGAAGAAGCTGGTGCCTC
TCTCTTCTT 
TATTCCCTGTAATAGAAGGTAGGATTTGAA
AAAAAGCAGGACTCCACCTCTGTATTCCCC
CGTGCTTTACCTTCTGGCATCATGAAAAGCT
GCCATGATT 
CTGTGGTGTTCTAAGGAATTAAATGCACTG
GAGCTTTAAGAGCTCAACGTGTTTCCCTTTG 
Transcription 
It is suggested that MRPL1 gene which is located 
closely to C2orf3 with head-head orientation and 
that they are co-regulated (Anthoni et al., 2007). 
There are several alternative spliced forms for 
mRNA expression: The initial report on a cDNA that 
encompass the full coding region is 2661bp in length 
(Takimoto  et al., 1999). 
Protein 
Description 
Encodes 781 amino acids  
Amino acid sequence: (Uniprot : P16383) 
MAHRPKRTFRQRAADSSDSDGAEESPAEPGA
PRELPVPGSAEEEPPSGGGRAQVAGLPHRVRG
PRGRGRVWASSRRATKAAPRADEGSESRTLD
VSTDEE 
DKIHHSSESKDDQGLSSDSSSSLGEKELSSTVK
IPDAAFIQAARRKRELARAQDDYISLDVQHTS
SISGMKRESEDDPESEPDDHEKRIPFTLRPQTL
RQ 
RMAEESISRNEETSEESQEDEKQDTWEQQQM
RKAVKIIEERDIDLSCGSGSSKVKKFDTSISFPP
VNLEIIKKQLNTRLTLLQETHRSHLREYEKYV
QDV 
KSSKSTIQNLESSSNQALNCKFYKSMKIYVEN
LIDCLNEKIINIQEIESSMHALLLKQAMTFMKR
RQDELKHESTYLQQLSRKDETSTSGNFSVDEK
TQW 
ILEEIESRRTKRRQARVLSGNCNHQEGTSSDD
ELPSAEMIDFQKSQGDILQKQKKVFEEVQDDF
CNIQNILLKFQQWREKFPDSYYEAFISLCIPKL
LNP 
LIRVQLIDWNPLKLESTGLKEMPWFKSVEEF
MDSSVEDSKKESSSDKKVLSAIINKTIIPRLTD
FVEFLWDPLSTSQTTSLITHCRVILEEHSTCEN
EVS 
KSRQDLLKSIVSRMKKAVEDDVFIPLYPKSAV
ENKTSPHSKFQERQFWSGLKLFRNILLWNGLL
TDDTLQELGLGKLLNRYLIIALLNATPGPDVV
KKCN 
QVAACLPEKWFENSAMRTSIPQLENFIQFLLQ
SAHKLSRSEFRDEVEEIILILVKIKALNQAESFI
GEHHLDHLKSLIKED 
Expression 
C2orf3 protein with molecular weight of 89 kD are 
observed in human cancer cell line, and localizes in 
nucleoplasm and nucleolus. 
Function 
C2orf3 plays a role in pre-mRNA splicing, by 
forming a complex with DHX15 (hPrp43) and  
TFIP11 (Yoshimoto et al., 2014). As these proteins 
are present in post-splicing intron complex, C2orf3 
protein may play a role in post-splicing turnover of 
mRNA. The study with and antibody specific to 
C2ofr3 protein showed that this protein is present 
nucleoplasm and nucleoli.  
 
After splicing reaction, pre-mRNA releases intron 
RNA complex, which contains uridine-rich small 
nuclear RNAs (snRNAs; U1, U2, U4, U5 and U6) 
PRPF19complex, hnRNP proteins and TFIP11. A 
RNA helicase hPrp43 removes the several factors 
from the complex, leaving lariat RNA intron, which 
is then subject to linearization by a debranching 
enzyme DBR1 (Wen et al., 2008; Yoshimoto et al., 
2009).C2orf3 protein was shown to form a complex 
with tuftelin-interacting protein (TFIP11) and 
hPrp43, which play a role in post-splicing turnover 
of mRNA. Through its amino terminal, TFIP11 
binds to a RNA helicase hPrp43 that plays a role in 
the dissociation of snRNAs from a lariat intron in 
vitro. C2orf3 preferentially associates with lariat 
intron in the splicing reaction and C2orf3-deleted 
nuclear extracts showed a significant repression of 
splicing of pre-mRNA in vitro (Yoshimoto et al., 
2014). The presence of C2orf3 protein in nucleoli 
suggest a potential role in rRNA processing/or 
nucleoli structure (Yoshimoto et al., 2014). 
Implicated in 
Although it is not conclusive, C2orf3 is suggested to 
be a causing gene for dyslexia. 
Dyslexia 
The locus containing the C2orf3 gene on 
Chromosome 2p12 has been shown to link to 
dyslexia. It had been reported that the genomic 
regions responsive for human dyslexia, such 
DYXC1/EKN1, KIAA0319 and DCDC, and 
RUBO1, are located on human chromosome 15, 6 
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and 3, respectively (McGrath et al., 2006). In 1999, 
It was shown that a new region for dyslexia, DYX3, 
on human chromosome 2 was identified (Fagerheim 
et al., 1999). Subsequently, a study on Finnish and 
German families disclosed that DYX3 was present 
on chromosome 2p12, spanning 157 kbp. It was 
shown that there are only three genes, FLJ1339, 
MRPL1 and C2ORF3, in this region and that the 
latter two genes are closely located with positions in 
a head-to-head manner respective for transcriptional 
orientation, suggesting that both genes are 
transcriptionally co-regulated (Anthoni et al., 2007). 
Further analyses on several affected families 
revealed an overlapping region with risk haplotype 
within the 157 kbp region, delineating to 16 kbp, 
which located in an intergenic region between 
FLJ1339 and MRPL1/C2ORF3 genes. There is no 
SNP marker in the coding regions of MRPL1 and 
C2ORF3 genes by which coding change correlated 
with dyslexia, and the expressions of both genes are 
significant lower in carriers with risk haplotype 
compared with non-carriers. These results suggested 
that the 16 kbp region plays a role for transcriptional 
regulatory element and mutation in this element 
might lead to reduced expression of the genes, which 
could be a cause of dyslexia. While the expression of 
FLJ1339 in human brain, the expressions of 
MRPL1/C2ORF3 are high and significantly 
correlated with those of other dyslexia candidate 
genes of whichexpressions are also high in brain. 
Especially, the expression of C2ORF3 was 
correlated across the different parts of brain with 
those of other dyslexia candidate genes, DYXC1, 
RUBO1 and DCDC2 (Anthoni et al., 2007). 
Neuroimaging analyses revealed a significant 
association between a SNP marker and white matter 
volume of the posterior parts of the corpus callosum 
and cingulum (Scerri et al., 2012). In contrary to the 
studies described above, the studies on the 
populations of Australia  and Inida showed non-
significant association for the SNP marker for 
MRPL1/C2ORF3 with dyslexia (Paracchini et al., 
2011 : Venkatesh et al., 2013). 
To be noted 
Previouly described GCF cDNA is an artificial 
fusion molecule between two different cDNAs, in 
which the 3' side of the molecule is derived from 
C2orf3 cDNA. 
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